Two-year outcomes from the Cook IVC Filter (CIVC) Study

Richard J Van Allan; Bob Smouse; Richard G McWilliams; Jennifer A Brown; John A Kaufman; Edem Segbefia; Robert J Feezor

doi:10.1016/j.jvir.2024.12.586

Two-year outcomes from the Cook IVC Filter (CIVC) Study

J Vasc Interv Radiol. 2024 Dec 28:S1051-0443(24)01375-7. doi: 10.1016/j.jvir.2024.12.586. Online ahead of print.

Authors

Richard J Van Allan¹, Bob Smouse², Richard G McWilliams³, Jennifer A Brown⁴, John A Kaufman⁵, Edem Segbefia⁶, Robert J Feezor⁷

Affiliations

¹ Section of Interventional Radiology, Department of Imaging, Cedars-Sinai Medical Center, Los Angeles, CA.
² Department of Radiology, University of Illinois College of Medicine, Peoria, IL.
³ Department of Radiology, Liverpool University Hospitals, Liverpool, United Kingdom.
⁴ Cook Research Incorporated, West Lafayette, IN. Electronic address: JenniferA.Brown@CookMedical.com.
⁵ Department of Interventional Radiology, Oregon Health and Science University, Portland, OR; Cook Medical, Bloomington, IN.
⁶ Cook Research Incorporated, West Lafayette, IN.
⁷ Vascular Surgery, UF Health - Halifax Health, University of Florida, Daytona Beach, FL.

PMID: 39736440
DOI: 10.1016/j.jvir.2024.12.586

Abstract

Purpose: Report 2-year outcomes from a prospective, multicenter, non-randomized, single-arm study designed to further assess the safety and effectiveness of the Celect and the Günther Tulip Vena Cava Filters.

Materials and methods: The BLIND study enrolled patients requiring temporary or permanent IVC filter placement for the prevention of pulmonary embolism (PE). The primary effectiveness endpoint was the rate of technical placement success and 12-month freedom from new symptomatic PE while a filter was indwelling. The primary safety endpoint was the rate of 12-month freedom from major adverse events (MAEs). The primary endpoints were assessed for the Celect stratum, and secondary endpoints and secondary measures were assessed for the Celect stratum and Günther Tulip stratum. Follow-up was through 2 years or 1 month following retrieval.

Results: Between 2014 and 2017, 473 patients (57.3% male; mean age 61.1±16.1 years) were enrolled at 28 institutions; 324 in the Celect stratum and 149 in the Günther Tulip stratum. Filters were primarily placed for current DVT (48.4%) and/or current PE (20.7%). The primary effectiveness endpoint rate was 97.8%. The protocol analysis yielded a primary safety rate of 81.5% (p=0.369); however, the post-hoc analysis resulted in a primary safety rate of 86.7% (p=0.001). The rate of successful filter retrieval was 94.9%. Only two patients had symptomatic filter leg interactions with the IVC. One death was adjudicated as device-/procedure-related.

Conclusion: BLIND study results support the safety and effectiveness of the Celect and Günther Tulip filters for the prevention of PE.